Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium

Authors :: Trabert, Britton
Poole, Elizabeth M.
White, Emily
Visvanathan, Kala
Adami, Hans-Olov
Anderson, Garnet L.
Brasky, Theodore M.
Brinton, Louise A.
Fortner, Renee T.
Gaudet, Mia
Hartge, Patricia
Hoffman-Bolton, Judith
Jones, Michael
Lacey, James V.
Larsson, Susanna C.
Mackenzie, Gerardo G.
Schouten, Leo J.
Sandler, Dale P.
O'Brien, Katie
Patel, Alpa V.
Peters, Ulrike
Prizment, Anna
Robien, Kim
Setiawan, Wendy V.
Swerdlow, Anthony
van den Brandt, Piet A.
Weiderpass, Elisabete
Wilkens, Lynne R.
Wolk, Alicja
Wentzensen, Nicolas
Tworoger, Shelley S.
Source :: Obstetrical and Gynecological Survey; October 2018, Vol. 73 Issue: 10 p576-578, 3p
Publication Year :: 2018
Abstract: (Abstracted from J Natl Cancer Inst2018; doi: 10.1093/jnci/djy100)The most fatal gynecologic cancer is ovarian cancer. This is largely due to its delayed symptom presentation and lack of early detection strategies.

Full Text Access

Tools